Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy

M. T. Schweizer, X. C. Zhou, H. Wang, T. Yang, F. Shaukat, A. W. Partin, M. A. Eisenberger, E. S. Antonarakis

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences